Session I: COVID-19 and GI Cancer
– Medizinische Universität Wien
The study authors found that the main third-line treatment goals for patients with mCRC remained the same during the COVID-19 pandemic though, there were changes to the daily practice patterns. Increased use of oral versus IV therapies was observed, and more follow-up and monitoring procedures were undertaken closer to home. Patients visited hospitals less frequently, with a shift toward virtual consultations/telemedicine. According to the authors, these practices are thought to continue for the foreseeable future which suggests that there is a need to further develop and invest in all aspects of digital health.